Louise Martin-Carpenter

Statistics

Publications

Citations

H-Index

Active since

2013

Affiliations

GlaxoSmithKline (United States)(Current)

GlaxoSmithKline (United Kingdom)

Research Triangle Park Foundation

Louise Martin-Carpenter is an author at GlaxoSmithKline (United States) specializing in antiviral therapy, antiretroviral therapy, and product safety profile.

Publications per year

2013–2014

Publications

Dolutegravir: Clinical and Laboratory Safety in Integrase Inhibitor–Naive Patients

Lloyd Curtis, Garrett Nichols, Chris Stainsby et al. · HIV Clinical Trials · 2014 · 63 citations

Pharmacy, Pharmacology, Pharmacotherapy +17

Prevalent Polymorphisms in Wild-Type HIV-1 Integrase Are Unlikely To Engender Drug Resistance to Dolutegravir (S/GSK1349572)

Cindy Vavro, Samiul Hasan, Heather M. Madsen et al. · Antimicrobial Agents and Chemotherapy · 2013 · 19 citations · Full text

Life Sciences, Molecular Biology, Molecular Genetics +17

1–2 of 2